Tumor Response Comparison by Different Criteria in Patients with Newly Diagnosed Glioblastoma
| Response evaluation | ||
| Patient no. | RANO | ΔVOLT1–3 |
| 1 | SD | −73% |
| 2 | SD | −70% |
| 3 | SD | −58% |
| 4 | PR | −81% |
| 5 | PR | −90% |
| 6 | SD | −36% |
| 7 | SD | −42% |
| 8 | CR | −100% |
| 9 | PD | −58% |
| 10 | CR | −100% |
| 11 | PD | 23% |
| 12 | PR | −55% |
| 13 | SD | −57% |
| 14 | PR | −71% |
| 15 | SD | −27% |
| 16 | SD | −22% |
| 17 | PR | −76% |
| 18 | SD | 0% |
| 19 | PR | −53% |
| 20 | PD | 62% |
| 21 | CR | −73% |
| 22 | PD | 65% |
| 23 | PR | −66% |
| 24 | SD | −13% |
| 25 | CR | −100% |
ΔVOLT1–3 was calculated by (VOLT3 − VOLT1)/VOLT1 on MR images.
ΔVOLT1–3 = change in lesion volume from T1 to T3 on MRI; SD = stable disease; PR = partial response; CR = complete response; PD = progressive disease.